Nascent Biotech Inc
OTC:NBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nascent Biotech Inc
OTC:NBIO
|
US |
|
Reviva Pharmaceuticals Holdings Inc
OTC:RVPH
|
US |
|
T
|
Tekcapital PLC
OTC:TEKCF
|
UK |
|
C
|
Chugoku Bank Ltd
F:UGO
|
JP |
|
Stuhini Exploration Ltd
XTSX:NOVA
|
CA |
|
A
|
Ai Robotics Inc
TSE:247A
|
JP |
|
F
|
Focus Impact Acquisition Corp
NASDAQ:FIAC
|
US |
|
P
|
Primoco UAV SE
PSE:PRIUA
|
CZ |
|
Seeen PLC
LSE:SEEN
|
UK |
|
Iris Acquisition Corp
OTC:IRAA
|
KY |
|
Usha Resources Ltd
XTSX:USHA
|
CA |
|
E
|
Eline Entertainment Group Inc
OTC:EEGI
|
US |
|
1st Colonial Bancorp Inc
OTC:FCOB
|
US |
|
E
|
Equity Metals Corp
OTC:EQMEF
|
CA |
Bankruptcy Probability
Nascent Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nascent Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Nascent Biotech Inc
OTC:NBIO
|
51.7k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
461.8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
55.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
31.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
25.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
25.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
25B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nascent Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nascent Biotech Inc has total debt of 59k USD. This includes both short-term (59k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
